Literature DB >> 39641

Is there a limbic system equivalent of tardive dyskinesia?

K L Davis, G S Rosenberg.   

Abstract

Long-term administration of antipsychotic drugs to animals induces super-sensitive mesolimbic postsynaptic dopamine receptors. It is possible that a similar process can occur in man. Following a reduction in the dose of antipsychotic medications, or their complete discontinuation, mesolimbic dopamine receptor supersensitivity could be reflected in rapid relapse of schizophrenic patients, the development of schizophrenic symptoms in patients with no prior history of schizophrenia, or in the necessity for ever-increasing doses of long-acting depot fluphenazine to maintain a remission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39641

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

Review 1.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

2.  Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.

Authors:  Maryann K Jacob; Peter Ash; W Edward Craighead
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-01-17       Impact factor: 4.785

3.  Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.

Authors:  H Y Meltzer; M A Lee; R Ranjan; E A Mason; P A Cola
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 4.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Increased mesolimbic dopamine binding following chronic haloperidol treatment.

Authors:  R S Kamer; A R Turi; P R Solomon; L J Kaplan
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.

Authors:  Shigenori Tadokoro; Naoe Okamura; Yoshimoto Sekine; Nobuhisa Kanahara; Kenji Hashimoto; Masaomi Iyo
Journal:  Schizophr Bull       Date:  2011-03-14       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.